Demographic and clinical characteristics of patients from AHOD who met the inclusion criteria for this study.

All parameters are median (IQR) unless otherwise stated.
cART-combination Antiretroviral therapy; MSM – men who have sex with men; NNRTI – non-nucleoside reverse transcriptase inhibitor; PI – protease inhibitor (boosted and unboosted); NRTI – nucleoside reverse transcriptase inhibitor.
*Others included injecting drug use, transfusion and unrecorded.
PIs included Atazanavir (boosted and unboosted) (5%), Lopinavir/Ritonavir (11%), Indinavir (boosted and unboosted) (32%), Nelfinavir (27%), Ritonavir (10%), Saquinavir (boosted and unboosted) (13%), Tipranavir (1%), Fosamprenavir (1%); NNRTIs included Delavirdine (1%), Efavirenz (44%), Nevirapine(55%);